By Aveluro Research Team · Editorial policy
DMC (DMC) is a company in Vietnam's Health Care sector, listed on HOSE. The stock last traded at 57,900 VND, little changed on the session, giving a market capitalization of 2.0 trillion VND.
On valuation, DMC trades at a price-to-earnings ratio of 9.9 and a price-to-book of 1.2. That is a discount to the Health Care sector average P/E of 22.2. Return on equity of 11.7% points to modest profitability relative to the company's equity base, above the sector average of 10.4%. Trailing earnings per share stand at 5,872 VND.
Aveluro tracks 5 news items mentioning DMC. The most recent catalyst was a sector sentiment event — "Foreign Ownership Dominates Vietnam's Top Pharma Stocks: DHG, IMP, DHT". Aveluro's composite model rates DMC 10.0/10 (Strong Buy), blending news sentiment, price momentum, and fundamentals.
Average daily volume over the past 10 sessions is roughly 2,000 shares; liquidity is relatively thin, so single headlines can move the price sharply. Comparable names in the Health Care sector include AGP, AMV and APC.
What matters now
Foreign Ownership Dominates Vietnam's Top Pharma Stocks: DHG, IMP, DHT
Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.
Low liquidity — thin average daily volume may result in wider spreads and price impact on larger orders.